Trial
NCT04152382
A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Psoriasis
Intervention
LY3462817 - IV
Why stopped
Terminated due to liver findings
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-15